Cytosorbents Corp (CTSO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q3 '16: 8.2M Q4 '16: 9.5M Q1 '17: 10.8M Q2 '17: 11.6M Q3 '17: 12.7M Q4 '17: 14.2M Q1 '18: 15.6M Q2 '18: 17.8M Q3 '18: 20.1M Q4 '18: 21.5M Q1 '19: 22.3M Q2 '19: 23.2M Q3 '19: 23.6M Q4 '19: 24.9M Q1 '20: 28.5M Q2 '20: 32M Q3 '20: 36.5M Q4 '20: 41M Q1 '21: 42.9M Q2 '21: 45.1M Q3 '21: 44.3M Q4 '21: 43.2M Q1 '22: 41.3M Q2 '22: 37.7M Q3 '22: 36.1M Q4 '22: 34.7M Q1 '23: 35.4M Q2 '23: 36.4M Q3 '23: 37.1M Q4 '23: 36.3M Q1 '24: 35.9M Q2 '24: 35.3M Q3 '24: 35.1M Q4 '24: 35.6M Q1 '25: 35.3M Q2 '25: 36.1M Q3 '25: 37M Q4 '25: 37.1M Q1 '26: 37.2M Q2 '26: 37.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '16: 4.7M Q4 '16: 5.6M Q1 '17: 6.4M Q2 '17: 7.2M Q3 '17: 8M Q4 '17: 9.6M Q1 '18: 11.1M Q2 '18: 13M Q3 '18: 14.4M Q4 '18: 15M Q1 '19: 15.1M Q2 '19: 15.5M Q3 '19: 16.2M Q4 '19: 17.6M Q1 '20: 20.5M Q2 '20: 22.6M Q3 '20: 25.9M Q4 '20: 30M Q1 '21: 31.5M Q2 '21: 34.2M Q3 '21: 33.9M Q4 '21: 32.1M Q1 '22: 30.7M Q2 '22: 26.3M Q3 '22: 22.6M Q4 '22: 20.7M Q1 '23: 19.8M Q2 '23: 20.8M Q3 '23: 22.8M Q4 '23: 22.4M Q1 '24: 23.8M Q2 '24: 24.3M Q3 '24: 23.9M Q4 '24: 24.9M Q1 '25: 24.2M Q2 '25: 24.5M Q3 '25: 25.9M Q4 '25: 26.5M Q1 '26: 26.4M Q2 '26: 26.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '16: -9.1M Q4 '16: -11.5M Q1 '17: -11M Q2 '17: -10.6M Q3 '17: -10.6M Q4 '17: -9.8M Q1 '18: -11.4M Q2 '18: -13.2M Q3 '18: -13.8M Q4 '18: -15.6M Q1 '19: -16.8M Q2 '19: -16.2M Q3 '19: -19.1M Q4 '19: -19M Q1 '20: -17.2M Q2 '20: -16.8M Q3 '20: -13.2M Q4 '20: -10.4M Q1 '21: -10.7M Q2 '21: -12.4M Q3 '21: -15.8M Q4 '21: -22.7M Q1 '22: -27.7M Q2 '22: -31.1M Q3 '22: -34.7M Q4 '22: -31.5M Q1 '23: -31.6M Q2 '23: -29.8M Q3 '23: -28.2M Q4 '23: -31.2M Q1 '24: -28M Q2 '24: -25M Q3 '24: -22.5M Q4 '24: -16.5M Q1 '25: -15.7M Q2 '25: -15.7M Q3 '25: -13.8M Q4 '25: -14.8M Q1 '26: -13.9M Q2 '26: -12.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '16: -10.4M Q4 '16: -11.9M Q1 '17: -11.6M Q2 '17: -10.4M Q3 '17: -10.2M Q4 '17: -8.5M Q1 '18: -9.9M Q2 '18: -14M Q3 '18: -15M Q4 '18: -17.2M Q1 '19: -19.1M Q2 '19: -16.8M Q3 '19: -20.7M Q4 '19: -19.3M Q1 '20: -17.8M Q2 '20: -17.2M Q3 '20: -11.1M Q4 '20: -7.8M Q1 '21: -8.6M Q2 '21: -10.4M Q3 '21: -15.9M Q4 '21: -24.6M Q1 '22: -29.4M Q2 '22: -35.6M Q3 '22: -41.4M Q4 '22: -32.8M Q1 '23: -31.2M Q2 '23: -26.4M Q3 '23: -23.4M Q4 '23: -29.2M Q1 '24: -28M Q2 '24: -26.2M Q3 '24: -19.7M Q4 '24: -20.7M Q1 '25: -16.1M Q2 '25: -9.9M Q3 '25: -10.3M Q4 '25: -8.2M Q1 '26: -11.8M Q2 '26: -18.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 6M 12M 18M Q4 '17: 5.5M Q1 '18: 5.8M Q2 '18: 6.1M Q3 '18: 6.7M Q4 '18: 7.5M Q1 '19: 7.7M Q2 '19: 7.7M Q3 '19: 7.4M Q4 '19: 7.4M Q1 '20: 8M Q2 '20: 9.4M Q3 '20: 10.6M Q4 '20: 11.1M Q1 '21: 11.4M Q2 '21: 10.9M Q3 '21: 10.5M Q4 '21: 11M Q1 '22: 10.6M Q2 '22: 11.4M Q3 '22: 13.4M Q4 '22: 14M Q1 '23: 15.7M Q2 '23: 15.5M Q3 '23: 14.2M Q4 '24: 10.7M Q1 '25: 11.1M Q2 '25: 11.6M Q3 '25: 11M Q4 '25: 10.6M Q1 '26: 10.8M Q2 '26: 10.6M Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '25 Q2 '26

Operating Cash Flow TTM

-30M -20M -10M 0 10M 20M 30M Q3 '16: -7.9M Q4 '16: -6.7M Q1 '17: -7.5M Q2 '17: -7.4M Q3 '17: -7.1M Q4 '17: -6.5M Q1 '18: -6.7M Q2 '18: -8.1M Q3 '18: -8.5M Q4 '18: -10.8M Q1 '19: -12.9M Q2 '19: -12.8M Q3 '19: -15.3M Q4 '19: -16.8M Q1 '20: -15.7M Q2 '20: -10.6M Q3 '20: -8.7M Q4 '20: -5.6M Q1 '21: -4.7M Q2 '21: -8.7M Q3 '21: -9.6M Q4 '21: -14M Q1 '22: -19.8M Q2 '22: -25.8M Q3 '22: -28.4M Q4 '22: -28.2M Q1 '23: -23.2M Q2 '23: -22.1M Q3 '23: -20.6M Q4 '23: -21.7M Q1 '24: -23.4M Q2 '24: -21.2M Q3 '24: -18.5M Q4 '24: -14.4M Q1 '25: -13.1M Q2 '25: -9.8M Q3 '25: -9.9M Q4 '25: -12.4M Q1 '26: -10.1M Q2 '26: -9.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '15: -9.7M Q4 '15: -9.5M Q1 '16: -8.2M Q2 '16: -8M Q3 '16: -8.1M Q4 '17: -7.5M Q1 '18: -7.8M Q2 '18: -9.3M Q3 '18: -9.4M Q4 '18: -11.5M Q1 '19: -13.6M Q2 '19: -13.4M Q3 '19: -16.1M Q4 '19: -17.5M Q1 '20: -16.4M Q2 '20: -11.2M Q3 '20: -9.4M Q4 '20: -6.3M Q1 '21: -5.6M Q2 '21: -10.3M Q3 '21: -11.8M Q4 '21: -17.6M Q1 '22: -23.7M Q2 '22: -33.4M Q3 '22: -35.8M Q4 '22: -34.3M Q1 '23: -29.1M Q2 '23: -23.3M Q3 '23: -21.2M Q4 '23: -22.2M Q1 '24: -23.5M Q2 '24: -21.5M Q3 '24: -18.8M Q4 '24: -14.7M Q1 '25: -13.3M Q2 '25: -10M Q3 '25: -10M Q4 '25: -12.5M Q1 '26: -10.2M Q2 '26: -9.3M Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '14: 12M Q2 '15: 28.8M Q2 '16: 25.4M Q3 '20: 41.6M Q1 '21: 43.3M Q2 '21: 43.3M Q3 '21: 43.4M Q1 '22: 43.5M Q2 '22: 43.6M Q3 '22: 43.6M Q1 '23: 43.7M Q2 '23: 44M Q3 '23: 44.4M Q1 '24: 54.4M Q2 '24: 54.3M Q3 '24: 54.5M Q1 '25: 60.7M Q2 '25: 67.2M Q3 '25: 62.8M Q1 '26: 62.7M Q2 '26: 62.8M Q2 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q3 '16: -0.36 Q4 '16: -0.47 Q1 '17: -0.46 Q2 '17: -0.40 Q3 '17: -0.38 Q4 '17: -0.31 Q1 '18: -0.35 Q2 '18: -0.48 Q3 '18: -0.51 Q4 '18: -0.56 Q1 '19: -0.61 Q2 '19: -0.53 Q3 '19: -0.64 Q4 '19: -0.60 Q1 '20: -0.55 Q2 '20: -0.52 Q3 '20: -0.33 Q4 '20: -0.20 Q1 '21: -0.20 Q2 '21: -0.23 Q3 '21: -0.36 Q4 '21: -0.61 Q1 '22: -0.72 Q2 '22: -0.86 Q3 '22: -0.99 Q4 '22: -0.76 Q1 '23: -0.72 Q2 '23: -0.61 Q3 '23: -0.54 Q4 '23: -0.64 Q1 '24: -0.58 Q2 '24: -0.52 Q3 '24: -0.36 Q4 '24: -0.38 Q1 '25: -0.29 Q2 '25: -0.18 Q3 '25: -0.18 Q4 '25: -0.13 Q1 '26: -0.19 Q2 '26: -0.29 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.